Cargando…

Efficacy and Safety of Nilutamide in Patients with Metastatic Prostate Cancer Who Underwent Orchiectomy: A Systematic Review and Meta-analysis

BACKGROUND: Prostate cancer is the sixth leading cause of death, among all cancer deaths By 2030, this burden is expected to increase with 1.7 million new cases and 499,000 new deaths. We aimed to evaluate the efficacy and safety of Nilutamide in metastatic prostate cancer (mPCa) patients who underw...

Descripción completa

Detalles Bibliográficos
Autores principales: Rashid, Muhammed, Shamshavali, K., Chhabra, Manik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040499/
https://www.ncbi.nlm.nih.gov/pubmed/30648519
http://dx.doi.org/10.2174/1574884714666190112151202